FDA New Guidance Document
-
Biologics
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
MARIETTA, Ga., Nov. 17, 2017 /PRNewswire/ — MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics…
Read More »